Arkolith/Insider Trading/HCWB/Form 4

Byam Rebecca

Chief Financial OfficerHCW Biologics Inc. (HCWB) · full profile →Form 4 · filed May 27, 2026
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 22, 2026Buy(P)14K$1.41$20K57K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 22, 2026Buy(P)14K—$018K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-26-025474) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML